Programme

Sustainable investing has been on the rise in recent years, compelled by stronger evidence and greater awareness. It has become increasingly clear that sustainability issues like climate change have a material impact on investment returns. However, the perfect translation of theory to action remains elusive. What are the most compelling investment risks and opportunities in themes like climate change? What roles should the public and private sectors play in driving positive outcomes? How has the COVID-19 pandemic affected the development of ‘Sustainable Finance’? What does the future of mainstream sustainable investing look like?

While the growing focus on sustainability offers new opportunities for long-term investors, portfolio exposure to sustainability risks and disruption also need to be carefully managed. In this session, we will explore how long-term investors are integrating sustainability considerations into their investment frameworks, strategies and processes, the challenges faced, and how these can be overcome.

Due to COVID-19, various countries imposed limits or bans on some medical supply exports. In response, the US recently passed the ‘Mitigating Emergency Drug Shortages Act’ to better track drug supplies and assess national security risks and is considering tightening laws to force federal agencies to buy locally-made pharmaceutical and medical equipment. Low labour costs, state subsidies and easier regulations helped make markets like China and India attractive as manufacturing hubs; reversing this trend will not be easy. What is the outlook for supply chain onshoring, drugs’ costs and pricing dynamics, and the potential winners and losers in post-pandemic world?

The pandemic is putting our healthcare system to the test. Healthcare leaders, stakeholders, and frontline responders are rising to the challenge and accelerating tech-enabled care delivery and clinical development. At this session, our panel will share their perspectives on how these innovative efforts are shaping global healthcare for the future.

At this session, Eric Yuan, Founder and CEO of Zoom, the world’s leading web-conferencing platform, will share his views on how people and businesses will adapt their communications needs in a post-COVID world. As the digital communications landscape evolves, what are the gaps and opportunities ahead?